Whole-Genome Analysis of Human Papillomavirus Type 16 Prevalent in Japanese Women with or without Cervical Lesions

Recent large-scale genomics studies of human papillomaviruses (HPVs) have shown a high level of genomic variability of HPV16, the most prevalent genotype in HPV-associated malignancies, and provided new insights into the biological and clinical relevance of its genetic variations in cervical cancer development. Here, we performed deep sequencing analyses of the viral genome to explore genetic variations of HPV16 that are prevalent in Japan. A total of 100 complete genome sequences of HPV16 were determined from cervical specimens collected from Japanese women with cervical intraepithelial neoplasia and invasive cervical cancer, or without cervical malignancies. Phylogenetic analyses revealed the variant distribution in the Japanese HPV16 isolates; overall, lineage A was the most prevalent (94.0%), in which sublineage A4 was dominant (52.0%), followed by sublineage A1 (21.0%). The relative risk of sublineage A4 for cervical cancer development was significantly higher compared to sublineages A1/A2/A3 (odds ratio = 6.72, 95% confidence interval = 1.78–28.9). Interestingly, a novel cluster of variants that branched from A1/A2/A3 was observed for the Japanese HPV16 isolates, indicating that unique HPV16 variants are prevalent among Japanese women.

[1]  R. DeSalle,et al.  Niche adaptation and viral transmission of human papillomaviruses from archaic hominins to modern humans , 2018, PLoS pathogens.

[2]  H. Adami,et al.  Human papillomavirus type 16 genomic variation in women with subsequent in situ or invasive cervical cancer: prospective population-based study , 2018, British Journal of Cancer.

[3]  S. Qiu,et al.  Differences in the viral genome between HPV-positive cervical and oropharyngeal cancer , 2018, PloS one.

[4]  S. Miyamoto,et al.  Within-Host Variations of Human Papillomavirus Reveal APOBEC Signature Mutagenesis in the Viral Genome , 2018, Journal of Virology.

[5]  Chase W. Nelson,et al.  HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis , 2017, Cell.

[6]  C. Meijer,et al.  Whole-Genome Sequencing and Variant Analysis of Human Papillomavirus 16 Infections , 2017, Journal of Virology.

[7]  Mario Schelhaas,et al.  A central region in the minor capsid protein of papillomaviruses facilitates viral genome tethering and membrane penetration for mitotic nuclear entry , 2017, PLoS pathogens.

[8]  S. de Sanjosé,et al.  Differential HPV16 variant distribution in squamous cell carcinoma, adenocarcinoma and adenosquamous cell carcinoma , 2017, International journal of cancer.

[9]  Y. Ke,et al.  Whole-Genome Analysis of Human Papillomavirus Types 16, 18, and 58 Isolated from Cervical Precancer and Cancer Samples in Chinese Women , 2017, Scientific Reports.

[10]  L. Banks,et al.  The PTPN14 Tumor Suppressor Is a Degradation Target of Human Papillomavirus E7 , 2017, Journal of Virology.

[11]  K. Münger,et al.  High-Risk Human Papillomavirus E7 Proteins Target PTPN14 for Degradation , 2016, mBio.

[12]  M. Yeager,et al.  HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women. , 2016, Journal of the National Cancer Institute.

[13]  M. Kuroda,et al.  VirusTAP: Viral Genome-Targeted Assembly Pipeline , 2016, Front. Microbiol..

[14]  Hongbing Shen,et al.  Analysis of human papillomavirus 16 variants and risk for cervical cancer in Chinese population. , 2016, Virology.

[15]  J. Espinosa,et al.  Role of the host restriction factor APOBEC3 on papillomavirus evolution , 2015, Virus evolution.

[16]  I. Kukimoto,et al.  Human papillomavirus genotype distribution in cervical intraepithelial neoplasia grade 2/3 and invasive cervical cancer in Japanese women. , 2014, Japanese journal of clinical oncology.

[17]  A. Cid,et al.  Prevalence of HPV 16 and HPV 18 Lineages in Galicia, Spain , 2014, PloS one.

[18]  R. Burk,et al.  Human Papillomavirus 16 Non-European Variants Are Preferentially Associated with High-Grade Cervical Lesions , 2014, PloS one.

[19]  Alexandros Stamatakis,et al.  RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies , 2014, Bioinform..

[20]  M. Muramatsu,et al.  APOBEC3 Deaminases Induce Hypermutation in Human Papillomavirus 16 DNA upon Beta Interferon Stimulation , 2013, Journal of Virology.

[21]  Y. Ishii,et al.  Genetic Variation of Human Papillomavirus Type 16 in Individual Clinical Specimens Revealed by Deep Sequencing , 2013, PloS one.

[22]  Jian-hua Liu,et al.  Genetic variations of E6 and long control region of human papillomavirus type 16 from patients with cervical lesion in Liaoning, China , 2013, BMC Cancer.

[23]  Alison A McBride,et al.  The papillomavirus E2 proteins. , 2013, Virology.

[24]  R. Burk,et al.  Human papillomavirus genome variants. , 2013, Virology.

[25]  T. Sasagawa,et al.  E6 and E7 variants of human papillomavirus‐16 and ‐52 in Japan, the Philippines, and Vietnam , 2013, Journal of medical virology.

[26]  S. Franceschi,et al.  HPV16 genetic variation and the development of cervical cancer worldwide , 2012, British Journal of Cancer.

[27]  Y. Ke,et al.  Whole Genome Sequencing and Evolutionary Analysis of Human Papillomavirus Type 16 in Central China , 2012, PloS one.

[28]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..

[29]  S. Franceschi,et al.  Human Papillomavirus Type 16 Genetic Variants: Phylogeny and Classification Based on E6 and LCR , 2012, Journal of Virology.

[30]  M. Fujita,et al.  A critical role of MYC for transformation of human cells by HPV16 E6E7 and oncogenic HRAS. , 2012, Carcinogenesis.

[31]  F. Zhang,et al.  Human Papillomavirus Type 16 Variant Analysis of E6, E7, and L1 Genes and Long Control Region in Cervical Carcinomas from Patients in Northeast China , 2011, Journal of Clinical Microbiology.

[32]  R. DeSalle,et al.  Sequence Imputation of HPV16 Genomes for Genetic Association Studies , 2011, PloS one.

[33]  F. Zhang,et al.  Human Papillomavirus Type 16 Variant Analysis of E6, E7, and L1 Genes and Long Control Region in Identification of Cervical Carcinomas in Patients in Northeast China , 2011, Journal of Clinical Microbiology.

[34]  N. Muñoz,et al.  Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. , 2010, The Lancet. Oncology.

[35]  E. de Villiers,et al.  Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. , 2010, Virology.

[36]  R. DeSalle,et al.  A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. , 2010, Cancer research.

[37]  A. Theamboonlers,et al.  Entire genome characterization of human papillomavirus type 16 from infected Thai women with different cytological findings , 2009, Virus Genes.

[38]  N. Muñoz,et al.  Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. , 2008, Vaccine.

[39]  J. M. van der Hulst,et al.  Human papilloma virus specific T cells infiltrating cervical cancer and draining lymph nodes show remarkably frequent use of HLA‐DQ and –DP as a restriction element , 2008, International journal of cancer.

[40]  H. Trottier,et al.  High grade cervical lesions are caused preferentially by non‐European variants of HPVs 16 and 18 , 2007, International journal of cancer.

[41]  C. Wheeler,et al.  Risk for High-Grade Cervical Intraepithelial Neoplasia Associated with Variants of Human Papillomavirus Types 16 and 18 , 2007, Cancer Epidemiology Biomarkers & Prevention.

[42]  C. Wheeler,et al.  Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. , 2006, Journal of the National Cancer Institute.

[43]  L. Brinton,et al.  Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. , 2003, Cancer research.

[44]  Y. Taketani,et al.  Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer , 2003, International journal of cancer.

[45]  H. Hausen.  Papillomaviruses and cancer: from basic studies to clinical application , 2002, Nature Reviews Cancer.

[46]  J. Salmerón,et al.  Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. , 2001, Journal of the National Cancer Institute.

[47]  K. Buetow,et al.  Human papillomavirus type 16 variants and risk of cervical cancer. , 2001, Journal of the National Cancer Institute.

[48]  Y. Taketani,et al.  Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population. , 2000, Cancer letters.

[49]  C. Wheeler,et al.  Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective , 1997, Journal of virology.

[50]  Kazutaka Katoh,et al.  Multiple alignment of DNA sequences with MAFFT. , 2009, Methods in molecular biology.

[51]  H. zur Hausen.  Papillomaviruses and cancer: from basic studies to clinical application , 2002, Nature reviews. Cancer.